Xianyou Maternity and Childcare Hospital, Putian, 351200, Fujian Province, China.
Fujian Medical University, Fujian Province, China.
Arq Bras Oftalmol. 2022 Sep-Oct;85(5):450-458. doi: 10.5935/0004-2749.20220075.
To investigate the antiproliferative effect of carboplatin-loaded surface-modified poly(lactide-co-glycolide) on retinoblastoma cells.
Carboplatin-loaded poly(lactide-co-glycolide) with or without sodium alginate surface modification was prepared using sodium alginate-poly(lactide-co-glycolide) and poly(lactide-co-glycolide). The zeta potential and carboplatin release behavior were investigated. The cellular uptake of the released drug was observed in the retinoblastoma cell line Y79. The inhibitory effect of carboplatin-loaded nanoparticles against the Y79 cell line was evaluated using methyl thiazolyl tetrazolium assay and western blot. Native carboplatin and void nanoparticles without carboplatin loading were used as controls.
The zeta potential was -(26.1 ± 3.1) mV for carboplatin-loaded poly(lactide-co-glycolide) and-(43.1 ± 8.1) mV for carboplatin-loaded sodium alginate-poly(lactide-co-glycolide). The burst release percentages of carboplatin-loaded poly(lactide-co-glycolide) and sodium alginate-poly(lactide-co-glycolide) were (40.0% ± 8.2%) and (18.9% ± 4.3%) at 24 hours, respectively. A significant difference was identified regarding drug release between carboplatin-loaded sodium alginate-poly(lactide-co-glycolide) and carboplatin-loaded poly(lactide-co-glycolide). Fluorescence detection revealed that intense uptake of carboplatin into the cytoplasm of the Y79 cell line that was exposed to carboplatin-loaded sodium alginate-poly(lactide-co-glycolide). Carboplatin-loaded poly(lactide-co-glycolide) or sodium alginate-poly(lactide-co-glycolide) exposure inhibited proliferating cell nuclear antigen expression in Y79 cells on day 3. Extension of exposure to day 5 revealed that the sodium alginate-poly(lactide-co-glycolide) surface modification was superior to that of poly(lactide-co-glycolide) in terms of proliferating cell nuclear antigen inhibition. The cell viability test using methyl thiazolyl tetrazolium revealed a similar inhibitory effect. Furthermore, the carboplatin-loaded nanoparticles of lower concentration inhibited cell viability more strongly than native carboplatin of higher concentration in methyl thiazolyl tetrazolium assay.
Carboplatin-loaded sodium alginate-poly(lactide-co-glycolide) inhibited retinoblastoma cell proliferation with superior effect as compared with poly(lactide-co-glycolide) and native carboplatin. Sodium alginate surface modification offers a potential strategy for the sustained carboplatin release system.
研究载顺铂聚乳酸-共-羟基乙酸对视网膜母细胞瘤细胞的增殖抑制作用。
采用海藻酸钠-聚乳酸-共-羟基乙酸和聚乳酸-共-羟基乙酸制备载顺铂聚乳酸-共-羟基乙酸。研究了载顺铂聚乳酸-共-羟基乙酸的zeta电位和载顺铂释放行为。观察了载顺铂纳米粒在视网膜母细胞瘤 Y79 细胞系中的摄取情况。采用噻唑蓝比色法和 Western blot 法评价载顺铂纳米粒对 Y79 细胞系的抑制作用。以天然顺铂和无载顺铂的空白纳米粒作为对照。
载顺铂聚乳酸-共-羟基乙酸的 zeta 电位为-(26.1±3.1)mV,载顺铂海藻酸钠-聚乳酸-共-羟基乙酸的 zeta 电位为-(43.1±8.1)mV。载顺铂聚乳酸-共-羟基乙酸和海藻酸钠-聚乳酸-共-羟基乙酸在 24 小时时的顺铂突释百分比分别为(40.0%±8.2%)和(18.9%±4.3%)。载顺铂海藻酸钠-聚乳酸-共-羟基乙酸与载顺铂聚乳酸-共-羟基乙酸之间的药物释放有显著差异。荧光检测显示,暴露于载顺铂海藻酸钠-聚乳酸-共-羟基乙酸的 Y79 细胞系的细胞质中大量摄取了顺铂。载顺铂聚乳酸-共-羟基乙酸或海藻酸钠-聚乳酸-共-羟基乙酸暴露于 Y79 细胞 3 天后,增殖细胞核抗原的表达受到抑制。延长暴露至第 5 天,结果表明,在抑制增殖细胞核抗原方面,海藻酸钠-聚乳酸-共-羟基乙酸的表面修饰优于聚乳酸-共-羟基乙酸。噻唑蓝比色法细胞活力试验也显示出相似的抑制作用。此外,载顺铂纳米粒在较低浓度时比高浓度的天然顺铂在噻唑蓝比色法中更能强烈抑制细胞活力。
与聚乳酸-共-羟基乙酸和天然顺铂相比,载顺铂海藻酸钠-聚乳酸-共-羟基乙酸抑制视网膜母细胞瘤增殖的效果更好。海藻酸钠表面修饰为持续释放顺铂系统提供了一种潜在的策略。